Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.

NCT01093534 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

547

Enrollment

INDUSTRY

Sponsor class

Conditions

Detrusor Overactivity
Overactive Bladder

Interventions

DRUG: Placebo
DRUG: solifenacin

Sponsor

Astellas Pharma Inc